Prof. Dr.

Herbert Schreiber

updated 11.10.2015

Publications
[2015-1983; sorted by year of publication]

[Impact Factors acc. to Journal Citation Report (JCR) 2011]

I. Full papers:

43.
M Freidel, K Tiel‐Wilck, H Schreiber, A Prechtl, U Essner, M Lang (2014): Drugresistant MS spasticity treatment with Sativex® add-on and driving ability. Acta Neurol
Scand: DOI:10.1111/ane.12287 (Impact Factor 2.44)
42. A Sarkozy, D Hicks, J Hudson, SH Laval, R Barresi, D Hilton-Jones, M Deschauer, E
Harris, L Rufibach, E Hwang, R Bashir, MC Walter, S Krause, P van den Bergh, I Illa, I
Pénisson-Besnier, L De Waele, D Turnbull, M Guglieri, B Schrank, B Schoser, J Seeger, H
Schreiber, D Gläser, [......], P Ray, AH Schapira, R Swingler, C Turner, KR Wagner, P
Maddison, PJ Shaw, V Straub, K Bushby, H Lochmüller (2013): ANO5 gene analysis in a
large cohort of patients with anoctaminopathy: confirmation of male prevalence and
high occurrence of the common exon 5 gene mutation. Human Mutat 34:1111-1118.
(Impact Factor 5.05).
41. MC Walter, P Reilich, S Thiele, J Schessl, H Schreiber, K Reiners, W Kress, C MüllerReible, M Vorgerd, P Urban, B Schrank, M Deschauer, B Schlotter-Weigel, R Kohnen, H
Lochmüller (2013): Treatment of dysferlinopathy with deflazacort. A double-blind,
placebo-controlled clinical trial. Orphanet J of Rare Dis 8(1):26ff (Impact Factor 5.07)
40. C Bischoff, H Schreiber, A Bergmann (2012): Background information on multiple
sclerosis patients stopping ongoing immunmodulatory therapy: a multi-center study
in a community-based inviorment. J Neurol 259: 2347-2353. (Impact Factor 3.47)
39. A Sarkozy, M Deschauer, RY Carlier, B Schrank, J Seeger, MC Walter, B Schoser, P
Reilich, F Leturq, A Radunovic, [….], P Laforet, B Eymard, H Schreiber, D Hicks, SS Vaidya,
D Gläser, PG Carlier, K Bushby, H Lochmüller, V Straub (2012): Muscle MRI findings in
limb girdle muscular dystrophy type 2L. Neuromusc Disorders 22: Suppl.2:S122-129.
(Impact Factor 2.79)
38. H Schreiber, K Kiltz, M Lang, P Flachenecker, H Meissner, M Freidel, H Herbst, E
Scholz, W Hofmann, E Schlegel, W Elias, K Gehring, U Eckhardt, A Bergmann, G
Reifschneider, S Ries, E Rupp, C Ring (2010): Fatigue, Kognition und Persönlichkeit bei
Patienten mit schubförmiger MS (RRMS). Der Nervenarzt 81:39-40 (Impact Factor 0.86).
37. Sperfeld AD, Müller HP, Unrath A, Jüngling F, Uttner I, Schreiber H, Ludolph AC,
Kassubek J (2009): Die zentralnervöse Beteiligung der spino-bulbären Muskelatrophie
Typ Kennedy: ganzhirnbasierte, multiparametische MRT-Untersuchungen und
neuropsychologische Befunde. Akt Neurologie 09:36 (Impact Factor 0.32).DOI:
10.1055/s-0029-1338905.

36. Soukup GR, Sperfeld AD, Uttner I, Karitzky J, Ludolph AC, Kassubek J, Schreiber H
(2009): Fronto-temporal cognitive function in X-linked spinal and bulbar muscular
atrophy (SBMA): a controlled study in 20 patients. J Neurol, 256:1869-1875 (Impact
Factor 3.47).
35. Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand
S, Nesler S, Rothhammer V, Lang M, Hartung HP, Hemmer B (2009): Enhancement of
chemokine expression by interferon beta therapy in patients with multiple sclerosis.
Arch Neurol 66:1-8. (Impact Factor 7.58)
34.
Pinkhardt EH, Jürgens R, Graf M, Ecker D, Born J, Becker W, Ludolph AC, Schreiber
H (2008): Signs of impaired selective attention in patients with amyotrophic lateral
sclerosis (ALS). J Neurol 255:532-538 (Impact Factor 3.47).
33.
Riesner HJ, Zeitler C, Schreiber H, Wild A (2008): Eine additive Therapie
chronischer Schmerzen bei fortgeschrittener Gon/Coxarthrose mit dem selektiven
Serotonin-Reuptake-Hemmer Fluvoxamin (Fevarin). Z Orthop Unfall 146:742-746.
(Impact Factor 0.42).
32.
Deschauer M, Morgenroth A, Joshi PR, Gläser D, Chinnery PP, Aasly J, Schreiber H,
Knape M, Zierz S, Vorgerd M. (2007): Analysis of spectrum and frequencies of
mutations in Mc Ardle disease. J Neurol 254(6):797-802. DOI 10.1007/S00415-006-0447x (online) (Impact Factor 3.47).
31.
Uttner I, Mottaghy FM, Schreiber H, Riecker A, Ludolph AC, Kassubek J (2006):
Primary progressive aphasia accompanied by environmental sound agnosia: a
neuropsychological, MRI and PET study. Psychiatry Research: Neuroimaging 146:191197. (Impact Factor 2.96).
30.
Brummer D, Walter MC, Palmbach M, Knirsch U, Karitzky J, Tomczak R, Braun C,
Grundhoff N, Bornemann A, Müller CR, Lochmüller H, Schreiber H (2005): Long-term MRI
and clinical follow-up of symptomatic and presymptomatic carriers of dysferlin gene
mutations. Acta Myologica 24(1):6-16. (Impact Factor 0.51)
29. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, Ludolph
AC (2005): Cognitive function in bulbar- and spinal-onset ALS – a longitudinal study in
52 patients J Neurol 252:772-781 (Impact Factor 3.47).
28. Walter MC, Petersen JA, Stucka R, Fischer D, Schröder R, Vorgerd M, Schroers A,
Schreiber H, Hanemann CO, Knirsch U, Rosenbohm A, Huebner A, Barisic N, Horvath R,
Komoly S, Reilich P, Müller-Felber W, Pongratz D, Müller JS, Auerswald EA, Lochmüller H
(2004): FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German
patients. J Med Genet 41(4):1-7 (Impact Factor 6.36).
27. Butz M, Koch MC, Müller-Felber W, Lemmers RJLF, van der Maarel SM, Schreiber H
(2003): Facioscapulohumeral muscular dystrophy – phenotype-genotype correlation
in patients with borderline D4Z4 repeat numbers. J Neurol 250:932-937 (Impact Factor
3.47).
26. Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, Sperfeld A, Winter S, Mehrkens HH,
Ludolph AC, Schreiber H (2003): Longitudinal effects of noninvasive positive pressure
ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil
82(8):597-604 (Impact Factor 1.58).

2

25. Walter MC, Braun C, Vorgerd C, Poppe M, Thirion C, Schmidt C, Schreiber H, Knirsch
U, Brummer D, Müller-Felber W, Pongratz D, Müller-Höcker J, Hübner A, Lochmüller H
(2003): Variable reduction of caveolin-3 in patients with LGMD2B/MM. J Neurol
250:1431-1438 (Impact Factor 3.47)
24. Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Häussler J, Ludolph AC, Hanemann
CO (2002): X-linked bulbospinal neuronopathy. Kennedy Disease. Arch Neurol (JAMA
Neurology) 59:1921-1926 (Impact Factor 7.58).
23. Wollinsky KH, Hülser PJ, Brinkmeier H, Aulkemeyer P, Bössenecker W, HuberHartmann KH, Rohrbach P, Schreiber H, Weber F, Kron M, Büchele G, Mehrkens HH,
Ludolph AC, Rüdel R (2001): CSF filtration is an effective treatment of Guillain-Barre
syndrome. A randomized clinical trial. Neurology 57:774-780 (Impact Factor 8.31)
22. Busse K, Köhler J, Stegmann K, Pongratz D, Koch MC, Schreiber H (2000): An
inherited 4q35 EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulo-humeral muscular dystrophy (FSHD). Neuromusc Disord 10:178-181 (Impact
Factor 2.79)
21. Schreiber H, Baur-Seack K, Kornhuber HH, Wallner B, Friedrich JM, DeWinter IM,
Born J (1999): Brain morphology in adolescents at genetic risk for schizophrenia
assessed by qualitative and quantitative magnetic resonance imaging. Schizophr Res
40:81-86. (Impact Factor 4.74)
20. Kern W, Born J, Schreiber H, Fehm HL (1999): Central nervous system effects of
intranasally administered insulin during euglycemia in men. Diabetes 48:557-563
(Impact Factor 8.28)
19. Sperfeld A, Schreiber H, Reindl I, Kleber FX, Ludolph AC (1997): Die
Ergospirometrie - eine Methode zur Detektion mitochondrialer Cytopathien. Nervenarzt
70:155-161 (Impact Factor 0.68).
18. Schreiber H, Rothmeier J, Stolz-Born G, Born J, Rothenberger A, Jürgens R, Becker
W, Kornhuber HH (1997): Visually-guided saccadic eye movements in adolescents at
genetic risk for schizophrenia. Schizophr Res 25:97-109 (Impact Factor 4.74).
17. Rösche J, Maurer H, Schreiber H, Kornhuber HH (1997): Normale somato-sensibel
evozierte Potentiale beim Adie-Syndrom. Die Rolle der Ia-Fasern. Z EEG-EMG 28:4951. ([Impact Factor Akt Neurol 0.31)
16. Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1996): Elektrophysio-logische
Korrelate selektiver Aufmerksamkeit bei Kindern und Jugendlichen mit erhöhtem
Schizophrenie-Risiko. Z Kinder-Jugendpsychiat 24:282-292 (Impact Factor 0.99).
15. Lieb K, Denz E, Hess R, Schüttler R, Kornhuber HH, Schreiber H (1996): Preattentive
information processing as measured by backward masking and texton detection tasks
in adolescents at high genetic risk for schizophrenia. Schizophr Res 21:171-182 (Impact
Factor 4.74).
14. Schreiber H, Rothmeier J, Becker W, Jürgens R, Born J, Stolz-Born G, Westphal KP,
Kornhuber HH (1995a): Comparative assessment of saccadic eye movements,
psychomotor and cognitive performance in schizophrenics, their first-degree relatives
and control subjects. Acta Psychiat Scand 91:195-201. (Impact Factor 4.22).

3

13. Schreiber H, Stolz-Born G, Pietrowsky R, Kornhuber HH, Fehm HL, Born J (1995b):
Improved event-related potential signs of selective attention after the cholecystokininanalog ceruletide in healthy persons. Biol Psychiatry, 37:702-712. (Impact Factor 8.28).
12. Westarp ME, Schreiber H, Westarp MP, Westphal KP, Mauch E, Kornhuber HH
(1995): Cerebral magnetic resonance imaging pathology and cerebrospinal fluid
proteins in sporadic amyotrophic lateral sclerosis. Clin Neuropathol 4:228-232 (Impact
Factor 1.04).
11. Wollinsky KH, Minde A, Schreiber H, Kluger P, Mehrkens HH (1995): Effektivität der
Heimbeatmung bei Kleinkindern und Säuglingen. Med Klin 90:57-59. (Impact Factor
0.47).
10. Marshall L, Mölle M, Schreiber H, Fehm HL, Born J (1994): Scalp recorded direct
current potential shifts associated with the transition to sleep in man.
Electroencephalogr Clin Neurophysiol 91:346-352. (Impact Factor 2.29).
9.
Born J, Schwab B, Schwab R, Schreiber H (1993): Acute and long-term effects of
adrenocorticotropin and dexamethasone on the auditory brainstem response in
multiple sclerosis patients. J Neurol 241:75-80. (Impact Factor 3.47).
8.
Westarp ME, Bartmann P, Rössler J, Geiger E, Westphal KP, Schreiber H, Fuchs D,
Westarp MP, Kornhuber HH (1993): Antiretroviral therapy in sporadic adult amyotrophic
lateral sclerosis. NeuroReport 4:819-822. (Impact Factor 1.65).
7.
Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1992a): Event-related potential
correlates of impaired selective attention in children at high-risk for schizophrenia.
Biol Psychiatry 32:634-651. (Impact Factor 8.28).
6.
Schreiber H, Stolz-Born G, Heinrich H, Kornhuber HH, Born J (1992b): Attention,
cognition, and motor perseveration in adolescents at genetic risk for schizophrenia
and control subjects. Psychiat Res, 44:125-140. (Impact Factor 2.52).
5.
Schreiber H, Stolz-Born G, Rothmeier J, Kornhuber A, Kornhuber HH, Born J (1991):
Endogenous event-related brain potentials and psychometric performance in children
at risk for schizophrenia. Biol Psychiatry 30:177-189. (Impact Factor 8.28).
4.
Bayer H, Frei-Kleiner S, Schreiber H (1991): Schlafprobleme und nervöse
Störungen. Da hilft die Passionsblume. Studie mit 1377 Patienten. Ärztliche Praxis
43(21):13-16.
3.
Schreiber H, Stolz G, Rothmeier J, Kornhuber HH, Born J (1989): Prolonged
latencies of the N2 and P3 of the auditory event-related potential in children at risk for
schizophrenia. Eur Arch Psy Clin Neuro 238:185-188. (Impact Factor 3.49)
2.
Deecke L, Kornhuber HH, Lang W, Lang M, Schreiber H (1985): Timing function of
the frontal cortex in sequential motor and learning tasks. Human Neurobiology, 4: 143154. (Impact Factor 1.61/1985).
1.
Schreiber H, Lang M, Lang W, Kornhuber A, Heise B, Keidel M, Deecke L (1983):
Frontal hemispheric differences in the Bereitschaftspotential associated with writing
and drawing. Human Neurobiol 2:197-202. (Impact Factor 1.61/1985)

4

II.

Review Articles:

11. H Schreiber, M Lang, K Kiltz, C Lang (2015): Is personality profile a relevant
determinant of fatigue in multiple sclerosis. Front. Neurol. Vol. 6; 2; 1-7.
doi:10.3389/fneur.2015.00002.
10. K Baum, HJ Boldt, A Chan, L Harms, HP Hartung, BC Kieseier, T Korn, M Mäurer, U
Meier, H Schreiber, B Tackenburg, H Wiendl, T Ziemssen, R Gold (2014): Dimethylfumarat
in der Therapie der schubförmigen MS. Verträglichkeit und Management von
Nebenwirkungen. Nervenheilkunde 33:175-179.
9.
Koch MC, Schreiber H (2001): Fazioskapulohumerale Muskeldystrophie –
Klinische und molekulargenetische Aspekte. In R. Dengler & P. Pongratz (Hrsg).
Management of Neuromuscular Diseases. Letter Nr. 21, pp. 1-12; Arcis-Verlag, München.
8.
Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1998): Investigation of
electrophysiological correlates of attention and information processing as
vulnerability indicators for schizophrenia. J Psychophysiology, 12:286-300 [Impact
Factor 1.634].
7.
Schreiber H (1998): Neurologische Manifestationen immunologischer
Erkrankungen - Die Vaskulitiden. Ärztl. Praxis Neurol Psychiat 12:628-638.
6.
Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1996): Event-related brain
potentials and psychometric performance in adolescents at genetic risk for
schizophrenia. In Ogura C, Koga Y, Shimokochi M (eds). Recent advances in event-related
potential research. Elsevier, Amsterdam, pp.550-557.
5.
Schreiber H, Kornhuber HH (1993): Heutiger Stand der medikamentösen Therapie
des Parkinson-Syndroms. Jatros Neurologie 9:28-40
4.
Schreiber H, Born J, Stolz-Born G, Rothmeier J, Jürgens R, Rothenberger A,
Kornhuber A, Becker W, Kornhuber HH (1993): Schizophrenie - Zentralnervöse
Funktionsdefizite bei Risikokindern. TW Neurologie Psychiatrie, 7: 728-737
3.
Schreiber H, Kornhuber HH (1992): Das Parkinson-Syndrom. Aktuelle
Entwicklungen zur Pathogenese, Diagnostik und Therapie. Münch Med Wochenschr
134:302-305.
2.
Schreiber H, Stolz-Born G, Rothmeier J, Kornhuber HH, Rothenberger A, Born J.
(1992): Kinder schizophrener Eltern - Neurophysiologische Hinweise auf die
Hypofrontalität als Risikofaktor. In: Baumann P (ed). Biologische Psychiatrie der
Gegenwart. Springer, Wien, New York, pp:385-389.
1.
Schreiber H, Stolz-Born G, Rothmeier J, Kornhuber AW, Born J, Kornhuber HH
(1990): Evoked brain potentials and psychometric data in children at risk for
schizophrenia. In: Deecke L, JC Eccles, VB Mountcastle (eds). From Neuron to Action. An
Appraisal of fundamental and clinical Research. Springer, Berlin, Heidelberg, New York,
pp:489-494.

5

III. Book Chapters:
xxx
Herbert Schreiber, Michael Lang, Kristina Kiltz, Charlotte Lang (04.02.2015). Is
personality profile a relevant determinant of fatigue in Multiple Sclerosis?
doi: 10.3389/fneur.2015.00002. In: Dettmers C. & DeLuca J. eds. (2016). Fatigue in
Multiple Sclerosis. Lausanne: Frontiers media. Doi: 10.3389/978-2-88919-763-7
16.
Jurkat-Rott K, Schreiber H, Goebel HH, Lehmann-Horn F (2005): Progressive
Muskeldystrophien, Myotonien, periodische Paralysen, distale und kongenitale
Myopathien. In Wallesch CW (Hrsg). Neurologie. Diagnostik und Therapie in Klinik und
Praxis. 1. Auflage. Kapitel 57, 797-817. Elsevier. Urban & Fischer. ISBN: 3-437-23390-4
15. Schreiber H (2001): Störungen der peripheren Nerven. In F. Lehmann-Horn & A.C.
Ludolph (Hrsg.): Neurologische Therapie. 3. Aufl. Urban & Fischer Verlag. pp. 328-352.
ISBN:3-437-21620-1
14. Schreiber H (2001): Störungen des Bewegungsapparates. In F. Lehmann-Horn &
A.C. Ludolph (Hrsg.): Neurologische Therapie. 3. Aufl. Urban & Schwarzenberg Verlag,
München. pp. 433-443.
13. Schreiber H & Ludolph AC (1999): Degenerative Erkrankungen des
Nervensystems. Motoneuronerkrankungen und cerebelläre Ataxien. Therapiehandbuch.
Sonderdruck. Urban & Schwarzenberg Verlag, München. P6, 1-19.
12. Jürgens R, Becker W, Schreiber H, Fegert B, Klausmann S (1999): Saccadic
tracking in schizophrenia: Incidence of hypometria and intrusions influenced by
visual background and pace of stepping? In Becker W, Deubel H & Mergner T (eds).
Current Oculomotor Research. Physiological and psychological aspects. Plenum Press, New
York, pp. 447-450.
11. Schreiber H, Kornhuber HH (1995): Biologische Marker in der Psychiatrie:
Forschungskonzept und bisherige Ergebnisse am Beispiel der Schizophrenie. In: Lieb
K, Riemann D, Berger M (Hrsg). Biologisch-psychiatrische Forschung. Gustav Fischer
Verlag, Stuttgart, Jena, New York, pp:196-218.
10. Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1993): Event-related potential
correlates of selective attention in children at genetic risk for schizophrenia. In: Heinze
HJ & Münte TF (eds). New developments in event-related potentials. Birkhäuser, Boston,
pp:319-324.
9.
Schreiber H, Seack K, Born J, Wallner B, Friedrich JM, Kornhuber HH (1993): Hirnmorphologische Befunde bei Jugendlichen mit und ohne genetisches Schizophrenierisiko: Eine vergleichende NMR-Studie. In: Deecke L & Lang W (Hrsg). Kongressband
des Deutsch-Österreichischen Neurologenkongresses.
8.
Westarp ME, Hülser PJ, Schreiber H, Westphal KP, Kolde G, Horn-Jörgensen R,
Clausen Föhring B, Westarp MP, Kornhuber HH (1993): Human retrovirus involvement in
amyotrophic lateral sclerosis: A rationale for antiretroviral therapy? In: Serratrice G,
Pellissier JF, Pouget J, Blin O, Branger D, Turc F, Azulay JP (eds). Systeme nerveux,
muscles et maladies systemiques - acquisitions recentes. Expansion Scientifique Francaise,
Paris, pp:250-263.

6

7.
Schreiber H, Westarp MP, Hülser PJ, Westphal KP, Wollinsky KH, Westarp ME,
Mauch E, Laufen H, Kornhuber HH (1992): Dokumentation von Zeichen chronischer
Entzündung und multifokaler Demyelinisierung des ZNS bei
Motoneuronerkrankungen. Verh Dt Ges Neurol 7:701-704.
6.
Schreiber H, Stolz-Born G, Rothmeier J, Kornhuber HH, Rothenberger A, Born J.
(1992): Kinder schizophrener Eltern - Neurophysiologische Hinweise auf die
Hypofrontalität als Risikofaktor. In: Baumann P (ed). Biologische Psychiatrie der
Gegenwart. Springer, Wien, New York, pp:385-389.
5.
Westphal KP, Bauer J, Laupheimer H, Schreiber H, Westarp ME, Hülser PJ,
Baumgärtner K, Wollinsky KH, van Eick H, Kornhuber HH (1992): Verlangsamte
Progression der ALS während intrathekaler Therapie mit Interferon beta. Verh Dt Ges
Neurol 7:699-700.
4.
Schreiber H, Stolz-Born G, Rothmeier J, Kornhuber AW, Born J, Kornhuber HH
(1990): Evoked brain potentials and psychometric data in children at risk for
schizophrenia. In: Deecke L, JC Eccles, VB Mountcastle (eds). From Neuron to Action. An
Appraisal of fundamental and clinical Research. Springer, Berlin, Heidelberg, New York,
pp:489-494.
3.
Schreiber H, Stolz-Born G, Kornhuber HH, Born J (1990): Delayed endogenous
evoked brain potentials in two independent groups of children at risk for
schizophrenia. In: Brunia CHM, AWK Gaillard, A Kok (eds). Psychophysiological Brain
Research. Tilburg University Press, pp:227-231.
2.
Kornhuber ME, Kornhuber HH, Kornhuber J, Schreiber H, Westphal KP (1990):
Schizophrenia - autoimmune asthenia of the glutamate receptor? In: Stefanis CN et al
(eds). Psychiatry: A world perspective - Volume 2. Elsevier, Amsterdam, pp:215-219.
1.
Deecke L, Kornhuber HH, Schreiber H, Lang M, Lang W, Kornhuber A, Heise B,
Keidel M (1986): Bereitschaftspotential associated with writing and drawing. In:
McCallum WC, Zappoli R, Denoth F (eds). Cerebral psychophysiology: Studies in eventrelated potentials. EEG Suppl 38:245-247. Elsevier, Amsterdam.

7

IV: Case Reports, other publications:
5.
Bengel D, Susa, M, Schreiber H, Ludolph AC, Tumani H (2007): Early diagnosis of
rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s
rRNA gene sequence. Eur J Neurol 14(9):1067-70 [Impact Factor 3.85].
4.
Schreiber H (2003): Les dysferlinopathies. Observations longitudinales de
données cliniques, paracliniques et de l`imagerie à résonance magnétique dans des
familles regroupant des membres symptomatiques et présymptomatiques. Diplôme de
Myologie, Univ. Pierre et Marie Curie, Sorbonne VI, CHU Pitié-Salpêtrière, Paris.
3.
Heidegger S, Mattfeldt T, Rieber A, Wikstroem M, Kern P, Kern W, Schreiber H
(1997): Orbito-sphenoidal Aspergillus infection mimicking cluster headache: a case
report. Cephalalgia 17:676-679.[Impact Factor 6.04].
2.
Rothmeier J, Schreiber H, Fröscher W (1990): Myositis ossificans circumscripta
nach ungewöhnlichem "Hirntrauma". Fortschr. Med. 108 (21): 415-416.
1.
Frank P, Maunz M., Rösch R, Schreiber, H (1985): Mediscript. Kommentierte
Staatsexamensfragen zum 2. Abschnitt der ärztlichen Prüfung. Mediscript-Verlag

8

Sign up to vote on this title
UsefulNot useful